Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
H.R. 2914 the "Medicare IVIG Access Act of 2007" regarding improved access to immune globulins. Sec 4 regarding coverage of home administration of IVIG; Pharmacy enhancements for consideration to the Medicare Modernization Act - no specific legislation this reporting period; H.R. 6331 the "Medicare Improvements for Patients and Providers Act of 2008" - Sec. 154 regarding a delay in the competitive acquisition program for DME
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
WALGREEN COMPANY via WALGREEN COMPANY
2008 · third_quarter · Q3
H.R. 2914 Medicare IVIG Access Act of 2007 Sec. 4 regarding coverage of home administration of IVIG and reimbursement for services, supplies and equipment; Pharmacy enhancements for consideration to the Medicare Modernization Act no specific legislation this reporting period; H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008 Sec. 154 regarding a delay in the competitive acquisition program for DME.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
WALGREEN COMPANY via
Source: Senate LDA
H.R. 2914 the "Medicare IVIG Access Act of 2007" regarding improved access to immune globulins. Sec 4 regarding coverage of home administration of IVIG; Pharmacy enhancements for consideration to the Medicare Modernization Act - no specific legislation this reporting period
H.R. 2914 Medicare IVIG Access Act of 2007 Sec. 4 regarding coverage of home administration of IVIG and reimbursement for services, supplies and equipment; Pharmacy enhancements for consideration to the Medicare Modernization Act no specific legislation this reporting period; H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008 Sec. 154 regarding a delay in the competitive acquisition program for DME.
Medicare Improvements for Patients and Providers Act of 2008
Client: WALGREEN COMPANY · Firm: WALGREEN COMPANY
H.R. 2914 Medicare IVIG Access Act of 2007 Sec. 4 regarding coverage of home administration of IVIG and reimbursement for services, supplies and equipment; Pharmacy enhancements for consideration to the Medicare Modernization Act no specific legislation this reporting period; H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008 Sec. 154 regarding a delay in the competitive acquisition program for DME.
Medicare Improvements for Patients and Providers Act of 2008
Client: WALGREEN COMPANY · Firm: WALGREEN COMPANY
H.R. 2914 the "Medicare IVIG Access Act of 2007" regarding improved access to immune globulins. Sec 4 regarding coverage of home administration of IVIG; Pharmacy enhancements for consideration to the Medicare Modernization Act - no specific legislation this reporting period; H.R. 6331 the "Medicare Improvements for Patients and Providers Act of 2008" - Sec. 154 regarding a delay in the competitive acquisition program for DME
Medicare Home Infusion Therapy Coverage Act of 2007
Client: WALGREEN COMPANY · Firm: WALGREEN COMPANY
S. 1082, FDA Revitalization Act of 2007 as relates to MedGuides for prescription drugs, internet pharmacy regulation, and anti-counterfeiting of prescription drugs (track and trace); Medicare Part D as related to "fix" with regards to enrollment processing period -- no legislation introduced specific to this; National Provider ID (NPI) as related to date of implementation and look to delay with Administration (CMS) and Congress--no specific legislation. Medicaid prescription drug reimbursement as related to AMP (average manufacturer's price) and FULs (federal upper limits)--no specific legislation yet introduced during this timeframe; H.R. 2567, Medicare Home Infusion Pharmacy Coverage Act of 2007 as it relates to provisions for meaningful Medicare home infusion of prescription drugs benefit; H.R.2900, FDA Amendments Act of 2007, as related to provision dealing with MedGuides required for select prescription drugs;
Food and Drug Administration Amendments Act of 2007
Client: WALGREEN COMPANY · Firm: WALGREEN COMPANY
S. 1082, FDA Revitalization Act of 2007 as relates to MedGuides for prescription drugs, internet pharmacy regulation, and anti-counterfeiting of prescription drugs (track and trace); Medicare Part D as related to "fix" with regards to enrollment processing period -- no legislation introduced specific to this; National Provider ID (NPI) as related to date of implementation and look to delay with Administration (CMS) and Congress--no specific legislation. Medicaid prescription drug reimbursement as related to AMP (average manufacturer's price) and FULs (federal upper limits)--no specific legislation yet introduced during this timeframe; H.R. 2567, Medicare Home Infusion Pharmacy Coverage Act of 2007 as it relates to provisions for meaningful Medicare home infusion of prescription drugs benefit; H.R.2900, FDA Amendments Act of 2007, as related to provision dealing with MedGuides required for select prescription drugs;
H.R. 621 / S. 1484, Home Oxygen Patient Protection Act of 2007 as relates to removal of 36-month oxygen rental cap
Methamphetamine Production Prevention Act of 2008
Client: WALGREEN COMPANY · Firm: WALGREEN COMPANY
S. 1276, Methamphetamine Production Prevention Act of 2007 as related to electronic logbooks and tracking of methamphetamine precursor chemicals, i.e. pseudoephredine; Dextromethorphan as related to age limits on sales of products containing dextromethorphan--no legislation introduced.
H.R. 621 / S. 1484, Home Oxygen Patient Protection Act of 2007 as relates to removal of 36-month oxygen rental cap
2008 · second_quarter · Q2
H.R. 2914 the "Medicare IVIG Access Act of 2007" regarding improved access to immune globulins. Sec 4 regarding coverage of home administration of IVIG; Pharmacy enhancements for consideration to the Medicare Modernization Act - no specific legislation this reporting period; H.R. 6331 the "Medicare Improvements for Patients and Providers Act of 2008" - Sec. 154 regarding a delay in the competitive acquisition program for DME
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
WALGREEN COMPANY via WALGREEN COMPANY
2008 · first_quarter · Q1
H.R. 2914 the "Medicare IVIG Access Act of 2007" regarding improved access to immune globulins. Sec 4 regarding coverage of home administration of IVIG; Pharmacy enhancements for consideration to the Medicare Modernization Act - no specific legislation this reporting period
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
WALGREEN COMPANY via WALGREEN COMPANY
2007 · mid_year · MM
S. 1082, FDA Revitalization Act of 2007 as relates to MedGuides for prescription drugs, internet pharmacy regulation, and anti-counterfeiting of prescription drugs (track and trace); Medicare Part D as related to "fix" with regards to enrollment processing period -- no legislation introduced specific to this; National Provider ID (NPI) as related to date of implementation and look to delay with Administration (CMS) and Congress--no specific legislation. Medicaid prescription drug reimbursement as related to AMP (average manufacturer's price) and FULs (federal upper limits)--no specific legislation yet introduced during this timeframe; H.R. 2567, Medicare Home Infusion Pharmacy Coverage Act of 2007 as it relates to provisions for meaningful Medicare home infusion of prescription drugs benefit; H.R.2900, FDA Amendments Act of 2007, as related to provision dealing with MedGuides required for select prescription drugs;
S. 1276, Methamphetamine Production Prevention Act of 2007 as related to electronic logbooks and tracking of methamphetamine precursor chemicals, i.e. pseudoephredine; Dextromethorphan as related to age limits on sales of products containing dextromethorphan--no legislation introduced.
H.R. 621 / S. 1484, Home Oxygen Patient Protection Act of 2007 as relates to removal of 36-month oxygen rental cap
Organized retail crime as related to federalizing the crime--no specific legislation introduced
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE